| Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge YC Chung, MS Ho, JC Wu, WJ Chen, JH Huang, ST Chou, YC Hu Vaccine 26 (15), 1855-1862, 2008 | 313 | 2008 |
| Peptide-based antifungal therapies against emerging infections A Matejuk, Q Leng, MD Begum, MC Woodle, P Scaria, ST Chou, ... Drugs of the Future 35 (3), 197, 2010 | 196 | 2010 |
| CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel V Plaks, JM Rossi, J Chou, L Wang, S Poddar, G Han, Z Wang, SQ Kuang, ... Blood, 2021 | 129 | 2021 |
| Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma N Scholler, R Perbost, FL Locke, MD Jain, S Turcan, C Danan, EC Chang, ... Nature Medicine, 1-11, 2022 | 120 | 2022 |
| Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds ST Chou, K Hom, D Zhang, Q Leng, LJ Tricoli, JM Hustedt, A Lee, ... Biomaterials 35 (2), 846-855, 2014 | 74 | 2014 |
| Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus KS Huang, WH Lo, YC Chung, YK Lai, CY Chen, ST Chou, YC Hu Human gene therapy 18 (11), 1161-1170, 2007 | 51 | 2007 |
| Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme ST Chou, R Patil, A Galstyan, PR Gangalum, WK Cavenee, FB Furnari, ... Journal of Controlled Release 244, 14-23, 2016 | 46 | 2016 |
| Vaccines targeting the neovasculature of tumors A Matejuk, Q Leng, ST Chou, AJ Mixson Vascular cell 3 (1), 7, 2011 | 43 | 2011 |
| Increased tumor distribution and expression of histidine‐rich plasmid polyplexes Q Leng, ST Chou, PV Scaria, MC Woodle, AJ Mixson The journal of gene medicine 16 (9-10), 317-328, 2014 | 42 | 2014 |
| Surface-Modified HK: siRNA Nanoplexes with Enhanced Pharmacokinetics and Tumor Growth Inhibition ST Chou, Q Leng, P Scaria, JD Kahn, LJ Tricoli, M Woodle, AJ Mixson Biomacromolecules 14 (3), 752-760, 2013 | 39 | 2013 |
| Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo ST Chou, Q Leng, P Scaria, M Woodle, AJ Mixson Cancer gene therapy 18 (10), 707, 2011 | 38 | 2011 |
| Zinc Finger Nucleases: Tailor-made for Gene Therapy ST Chou, Q Leng, AJ Mixson Drugs of the future 37 (3), 183, 2012 | 33 | 2012 |
| Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma FL Locke, S Filosto, J Chou, S Vardhanabhuti, R Perbost, P Dreger, ... Nature Medicine, 1-12, 2024 | 26 | 2024 |
| siRNA nanoparticles: the future of RNAi therapeutics for oncology? ST Chou, AJ Mixson Nanomedicine 9 (15), 2251-2254, 2014 | 14 | 2014 |
| Direct Observation of Dynamic Mechanical Regulation of DNA Condensation by Environmental Stimuli A Lee, A Karcz, R Akman, T Zheng, S Kwon, ST Chou, S Sucayan, ... Angewandte Chemie 126 (40), 10807-10811, 2014 | 14 | 2014 |
| Product attributes of CAR T-cell therapy differentially associate with efficacy and toxicity in second-line large B-cell lymphoma (ZUMA-7) S Filosto, S Vardhanabhuti, MA Canales, X Poiré, LJ Lekakis, S de Vos, ... Blood Cancer Discovery 5 (1), 21-33, 2024 | 11 | 2024 |
| A Phase II Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity MJ Frigault, KME Gallagher, M Wehrli, B Valles, K Casey, K Lindell, ... Blood 138, 2814, 2021 | 10 | 2021 |
| Retreatment With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma in ZUMA-5 JC Chavez, CA Jacobson, AR Sehgal, SS Neelapu, DG Maloney, ... Blood 136, 2020 | 9 | 2020 |
| Buffering Capacity and Size of siRNA Polyplexes Influence Cytokine Levels Q Leng, ST Chou, PV Scaria, MC Woodle, AJ Mixson Molecular Therapy 20 (12), 2282-2290, 2012 | 9 | 2012 |
| Association of pretreatment (preTx) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard of care (SOC) in … FL Locke, J Chou, S Vardhanabhuti, R Perbost, P Dreger, BT Hill, C Lee, ... Journal of Clinical Oncology 40 (16_suppl), 7565-7565, 2022 | 7 | 2022 |
Archibald James MixsonUniversity of MarylandVerified email at som.umaryland.edu
